betoptic
novartis ireland limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - betaxolol
betoptic suspension single dose
novartis ireland limited - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - betaxolol
betoptic/pilo suspension
alcon canada inc - betaxolol (betaxolol hydrochloride); pilocarpine hydrochloride - suspension - 0.25%; 1.75% - betaxolol (betaxolol hydrochloride) 0.25%; pilocarpine hydrochloride 1.75% - beta-adrenergic agents
pilocarpine hydrochloride solution/ drops
sandoz inc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 10 mg in 1 ml - pilocarpine hydrochloride ophthalmic solution is indicated for the: . . . . none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pilocarpine hydrochloride ophthalmic solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pilocarpine hydrochloride ophthalmic solution is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.
pilocarpine hydrochloride- pilocarpine hydrochloride ophthalmic solution solution/ drops
somerset therapeutics, llc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride ophthalmic solution, is indicated for the: none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pilocarpine hydrochloride ophthalmic solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pilocarpine hydrochloride ophthalmic solution is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.
betoptic 0.5 base %w/v eye drops solution
ltt pharma limited - betaxolol hydrochloride - eye drops solution - 0.5 base %w/v
betoptic 0.5 %w/v eye drops solution
alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - beta blocking agents
betoptic 0.5% w/v eye drops, solution
pco manufacturing ltd. - betaxolol hydrochloride - eye drops, solution - 0.5% percent weight/volume - beta blocking agents1); betaxolol
betoptic 0.5% eye drops
immedica pharma ab - betaxolol hydrochloride - eye drops - 5mg/1ml
betoptic 0.25% suspension eye drops
immedica pharma ab - betaxolol hydrochloride - eye drops - 2.5mg/1ml